Table 1 Baseline characteristics of the study population
Before match | After match | ||||||||
|---|---|---|---|---|---|---|---|---|---|
NUx | AC | NAC | p-value | AC | NAC | p-value | SMD | ||
(n = 6627) | (n = 1984) | (n = 94) | (AC vs. NAC) | (n = 188) | (n = 94) | ||||
Age | 67.9 ± 10.4 | 64.2 ± 9.3 | 65.2 ± 9.4 | 0.294 | 65.0 ± 8.9 | 65.2 ± 9.4 | 0.875 | 0.020 | |
70.0 [61.0;76.0] | 65.0 [58.0;71.0] | 67.0 [60.0;72.0] | 66.0 [59.5;72.0] | 67.0 [60.0;72.0] | |||||
Age group | 0.213 | 1.000 | < 0.001 | ||||||
- <65 | 2236 (33.7%) | 922 (46.5%) | 37 (39.4%) | 74 (39.4%) | 37 (39.4%) | ||||
- ≥65 | 4391 (66.3%) | 1062 (53.5%) | 57 (60.6%) | 114 (60.6%) | 57 (60.6%) | ||||
Sex | 0.333 | 1.000 | < 0.001 | ||||||
- Male | 4643 (70.1%) | 1452 (73.2%) | 64 (68.1%) | 128 (68.1%) | 64 (68.1%) | ||||
- Female | 1984 (29.9%) | 532 (26.8%) | 30 (31.9%) | 60 (31.9%) | 30 (31.9%) | ||||
Diagnostic year | < 0.001 | 0.722 | 0.065 | ||||||
− 2004–2009 | 2062 (31.1%) | 779 (39.3%) | 19 (20.2%) | 43 (22.9%) | 19 (20.2%) | ||||
− 2010–2016 | 4565 (68.9%) | 1205 (60.7%) | 75 (79.8%) | 145 (77.1%) | 75 (79.8%) | ||||
CCI | 0.010 | 1.000 | < 0.001 | ||||||
- <4 | 4285 (64.7%) | 1455 (73.3%) | 57 (60.6%) | 114 (60.6%) | 57 (60.6%) | ||||
- ≥4 | 2342 (35.3%) | 529 (26.7%) | 37 (39.4%) | 74 (39.4%) | 37 (39.4%) | ||||